Cargando…

AAV Vectored Immunoprophylaxis for Filovirus Infections

Filoviruses are among the deadliest infectious agents known to man, causing severe hemorrhagic fever, with up to 90% fatality rates. The 2014 Ebola outbreak in West Africa resulted in over 28,000 infections, demonstrating the large-scale human health and economic impact generated by filoviruses. Zai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rghei, Amira D., van Lieshout, Laura P., Santry, Lisa A., Guilleman, Matthew M., Thomas, Sylvia P., Susta, Leonardo, Karimi, Khalil, Bridle, Byram W., Wootton, Sarah K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709665/ https://www.ncbi.nlm.nih.gov/pubmed/33182447 http://dx.doi.org/10.3390/tropicalmed5040169

Ejemplares similares

Overcoming Barriers to Preventing and Treating P. aeruginosa Infections Using AAV Vectored Immunoprophylaxis
por: Lopes, Jordyn A., et al.
Publicado: (2022)

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model
por: Campbell, Elena S. B., et al.
Publicado: (2023)

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
por: McAusland, Thomas M., et al.
Publicado: (2021)

Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models
por: Rghei, Amira D., et al.
Publicado: (2021)

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
por: Stegelmeier, Ashley A., et al.
Publicado: (2022)

Macrophage Depletion via Clodronate Pretreatment Reduces Transgene Expression from AAV Vectors In Vivo
por: Yu, Darrick L., et al.
Publicado: (2021)

Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
por: Santry, Lisa A., et al.
Publicado: (2017)

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
por: van Lieshout, Laura P., et al.
Publicado: (2022)

AAV vector distribution in the mouse respiratory tract following four different methods of administration
por: Santry, Lisa A., et al.
Publicado: (2017)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy
por: Rosales Gerpe, María C., et al.
Publicado: (2018)

Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation
por: Chan, Lily, et al.
Publicado: (2023)

Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections
por: Mould, Robert C., et al.
Publicado: (2017)

Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination
por: Sanders, John W., et al.
Publicado: (2017)

Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein
por: Stegelmeier, Ashley A., et al.
Publicado: (2020)

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
por: Stegelmeier, Ashley A., et al.
Publicado: (2021)

Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin
por: Mould, Robert C., et al.
Publicado: (2021)

Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration
por: Chan, Lily, et al.
Publicado: (2021)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
por: van Vloten, Jacob P., et al.
Publicado: (2021)

Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis
por: Balazs, Alejandro B., et al.
Publicado: (2011)

Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
por: Balazs, AB, et al.
Publicado: (2012)

A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency
por: Kang, Martin H., et al.
Publicado: (2020)

Myeloid Cells during Viral Infections and Inflammation
por: Stegelmeier, Ashley A., et al.
Publicado: (2019)

A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
por: Gary, Ebony N., et al.
Publicado: (2021)

Adeno-Associated Virus Vector Mediated Expression of an Oncogenic Retroviral Envelope Protein Induces Lung Adenocarcinomas in Immunocompetent Mice
por: Linnerth-Petrik, Nicolle M., et al.
Publicado: (2012)

Vectored ImmunoProphylaxis Protects Humanized Mice from Mucosal HIV Transmission
por: Balazs, Alejandro B., et al.
Publicado: (2014)

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
por: van Vloten, Jacob P, et al.
Publicado: (2022)

Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
por: Mucker, Eric M., et al.
Publicado: (2020)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
por: Tada, Takuya, et al.
Publicado: (2023)

Filovirus Entry
por: Simmons, Graham
Publicado: (2013)

Dendritic Cell-Based Vaccines Recruit Neutrophils to the Local Draining Lymph Nodes to Prime Natural Killer Cell Responses
por: Chan, Lily, et al.
Publicado: (2022)

The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell Populations
por: Chan, Lily, et al.
Publicado: (2023)

Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice
por: Chan, Lily, et al.
Publicado: (2023)

Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease
por: Warner, Bryce M., et al.
Publicado: (2021)

Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis
por: Kusma, Jennifer D., et al.
Publicado: (2023)

Passive Broad-Spectrum Influenza Immunoprophylaxis
por: Berry, Cassandra M., et al.
Publicado: (2014)

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
por: Hafezi, Bahareh, et al.
Publicado: (2021)

Undiscovered Bat Hosts of Filoviruses
por: Han, Barbara A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q42d96ummiqtace6cdriajs64v